Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 5 November 2026.

Announcements

6,266

Total raised

£165B

disclosed amounts

This month

£202M

raised so far

Seed
£20.3M

Accel-KKR led the majority investment to support product development and strategic acquisitions.

"AccessPay plays a crucial role in helping to optimise finance operations, increasing automation, improving cash visibility, and reducing the risk of fraud and error. It also has a reputation for delivering outstanding customer service,"
— Phil Cunningham, Managing Director
Seed
£200K

Jenson Ventures backed the oral care brand through its 2025/26 SEIS fund to support upcoming product launches.

"Tahir Oral Care is an exciting addition to our portfolio. The team has developed a genuinely differentiated product in a category that is ripe for innovation. We’re particularly impressed by their focus on user experience and brand, and we look forward to supporting them as they scale."
— Sarah Barber, CEO
Seed

Jenson Ventures has backed the property technology startup in its latest funding round to accelerate national scaling.

"Property maintenance sits at the heart of every property management operation, yet it remains one of the last areas to be properly modernised. Having Jenson lead our funding round is a real statement of intent. Their track record of backing ambitious founders at the earliest stage, and the support they bring beyond capital, makes them exactly the right partner as we scale."
— Sam Smith, CEO and founder
£8.7M

The funding round included participation from XTX Ventures and Macmillan Cancer Support to accelerate deployment and expand diagnostics.

"Cancer imaging volumes are rising rapidly but reporting capacity is not keeping pace. Our goal is to give clinicians faster, more confident decisions while reducing unnecessary interventions for patients. With our deep focus on prostate cancer and strong clinical validation across NHS pathways, we’re showing how AI can deliver earlier and more accurate diagnoses. In the NHS, few Trusts can confirm or rule out cancer within 28 days, and some patients can wait two months or longer. Lucida Medical is ideally placed to reduce this burden, and this funding will allow us to do that faster."
— Antony Rix, Co-founder and CEO
Growth
£3.0M

YFM Equity Partners backed the digital funeral planning provider to support its expansion and marketing efforts.

"Aura is well positioned at a point of structural change in the funeral services market. The team has built a differentiated, digital-first proposition that combines strong regulatory foundations with a high-quality customer experience. Importantly, they are doing so with a clear sense of purpose – helping to modernise and improve an industry that has historically underserved consumers. We were particularly impressed by the strength and ambition of the team, and their vision to build a broader end-of-life planning platform."
— Adam Hart, Investment Manager